Rituximab Plus Methotrexate With or Without Lenalidomide in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma
Clinical trial NCT04481815 · UNKNOWN
Trial details
- NCT number
- NCT04481815
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2023-12-30
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.